The brief
- ARPA-H selected Stanford in Feb 2026 to develop biomarkers for healthspan across seven research teams.
- PROSPR-IC creates the first FDA-grade Intrinsic Capacity score to forecast health outcomes up to 20 years.
- Stanford will validate the score in a one-year lifestyle intervention trial with digital health monitoring.
Technical approach
Combining existing datasets
PROSPR-IC integrates health records and biomarker measurements from multiple institutions into one unified database.
Intrinsic Capacity score
Biomarkers of physical, cognitive, mental and social health are combined into one score predicting long-term health trajectory and remaining healthy life.
Digital health technology
Stanford is developing digital health tools for home use to track physical activity, sleep, cognitive function and other markers during the intervention trial.

